CASE NO. 3 One of the great success stories in international trade in recent years has...
Fantastic news! We've Found the answer you've been seeking!
Question:
Transcribed Image Text:
CASE NO. 3 One of the great success stories in international trade in recent years has been the strong growth of India's pharmaceutical industry. The country used to be known for producing cheap knockoffs of patented drugs discovered by Western and Japanese pharmaceutical companies. This made the industry isolated in the global community. Because they made copies of patented products, and therefore violated intellectual property rights, Indian companies were not allowed to sell these products in developed markets. With no assurance that their intellectual property would be protected, foreign drug companies refused to invest in partner with, or buy from their Indian counterparts further limiting the business opportunities of Indian companies. In developed markets such as the United States, the best that Indian companies could do was to sell low-cost generic pharmaceuticals (generic pharmaceuticals are products whose patents have expired). In 2005, however, India signed an agreement with the World Trade Organization that brought the country' into compliance with WTO rules on intellectual property rights. Indian companies stopped producing counterfeit products. Secure in the knowledge that their patents would be respected, foreign companies started to do business with their Indian counterparts. For India, the result has been dramatic growth in its pharmaceutical sector. The sector generated sales of close to $30 billion in 2012-2013, more than two and a half times the figure of 2005. Driving this growth have been surging exports, which grew at 15 percent per annum between 2006 and 2012. In 2000, pharmaceutical exports from India amounted to around Slbillion. By 2012-2013, the figure was around 514.7 billion! Much of this growth has been the result of partnerships between Westem and Indian firms. Westem companies have been increasingly outsourcing manufacturing and packaging activities to India while scaling back some of these activities at home and in places such as Puerto Rico, which historically has been a major manufacturing hub for firms serving the U.S. market. India's advantages in manufacturing and packaging include relatively low wage rates, an educated workforce, and the widespread use of English as a business language. Westem companies have continued to perfom high value-added R&D, marketing, and sales activities, and these remain located in their home markets. When India was isolated in the global drug business, its nascent domestic industry set the foundations for today's growth. Local start-ups invested in the facilities required to discover and produce pharmaceuticals, creating a market for pharmaceutical scientists and workers in India. In turn, this drove the expansion of pharmaceutical programs in the country's universities, thereby increasing the supply of talent. Moreover, the industry's experience in the generic drug business during the 1990s and early 2000s has given it expertise in dealing with regulatory agencies in the United States and European Union. After 2005, this know-how made Indian companies more attractive as partners for Western enterprises. Combined with low labor costs, all these factors came together to make India an increasingly attractive location for the manufacturing of pharmaceuticals. The U.S. Federal Drug Administration (FDA) responded to the shift of manufacturing to India by opening two offices there to oversee manufacturing compliance and make sure safety was consistent with FDA-mandated standards. Today, the FDA has issued approvals to produce pharmaceuticals for sale in the United States to some 900 manufacturing plants in India, giving Indian companies a legitimacy that potential rivals in places such as China lack. For Western enterprises, the obvious attraction of outsourcing drug manufacturing to India is that it lowers their costs, enabling them to protect their earnings in an increasingly difficult domestic environment where government health care regulation and increased competition have put pressure on the pricing of many pharmaceuticals. Arguably, this also benefits consumers in the United States because lower pharmaceutical prices mean lower insurance costs, smaller pays, and ultimately lower out-of-pocket expenses than if those pharmaceuticals were still manufactured domestically. Offset against this economic benefit, of course, must be the cost of jobs lost in U.S. pharmaceutical manufacturing. Indicative of this trend, total manufacturing. Indicative of this trend, total manufacturing employment in this sector fell by 5 percent between 2008 and 2010. QUESTIONS TO ANSWER 1. Explain how might (a) U.S. pharmaceutical companies and (b) U.S. consumers benefit from the rise of the Indian pharmaceutical industry? (5 Marks) 2. Do the benefits from trade with the Indian pharmaceutical sector outweigh the losses for US pharmaceutical market? Discuss. (5 Marks) 3. What international trade theory (or theories) best explains the rise of India as a major exporter of pharmaceuticals? (5 Marks) CASE NO. 3 One of the great success stories in international trade in recent years has been the strong growth of India's pharmaceutical industry. The country used to be known for producing cheap knockoffs of patented drugs discovered by Western and Japanese pharmaceutical companies. This made the industry isolated in the global community. Because they made copies of patented products, and therefore violated intellectual property rights, Indian companies were not allowed to sell these products in developed markets. With no assurance that their intellectual property would be protected, foreign drug companies refused to invest in partner with, or buy from their Indian counterparts further limiting the business opportunities of Indian companies. In developed markets such as the United States, the best that Indian companies could do was to sell low-cost generic pharmaceuticals (generic pharmaceuticals are products whose patents have expired). In 2005, however, India signed an agreement with the World Trade Organization that brought the country' into compliance with WTO rules on intellectual property rights. Indian companies stopped producing counterfeit products. Secure in the knowledge that their patents would be respected, foreign companies started to do business with their Indian counterparts. For India, the result has been dramatic growth in its pharmaceutical sector. The sector generated sales of close to $30 billion in 2012-2013, more than two and a half times the figure of 2005. Driving this growth have been surging exports, which grew at 15 percent per annum between 2006 and 2012. In 2000, pharmaceutical exports from India amounted to around Slbillion. By 2012-2013, the figure was around 514.7 billion! Much of this growth has been the result of partnerships between Westem and Indian firms. Westem companies have been increasingly outsourcing manufacturing and packaging activities to India while scaling back some of these activities at home and in places such as Puerto Rico, which historically has been a major manufacturing hub for firms serving the U.S. market. India's advantages in manufacturing and packaging include relatively low wage rates, an educated workforce, and the widespread use of English as a business language. Westem companies have continued to perfom high value-added R&D, marketing, and sales activities, and these remain located in their home markets. When India was isolated in the global drug business, its nascent domestic industry set the foundations for today's growth. Local start-ups invested in the facilities required to discover and produce pharmaceuticals, creating a market for pharmaceutical scientists and workers in India. In turn, this drove the expansion of pharmaceutical programs in the country's universities, thereby increasing the supply of talent. Moreover, the industry's experience in the generic drug business during the 1990s and early 2000s has given it expertise in dealing with regulatory agencies in the United States and European Union. After 2005, this know-how made Indian companies more attractive as partners for Western enterprises. Combined with low labor costs, all these factors came together to make India an increasingly attractive location for the manufacturing of pharmaceuticals. The U.S. Federal Drug Administration (FDA) responded to the shift of manufacturing to India by opening two offices there to oversee manufacturing compliance and make sure safety was consistent with FDA-mandated standards. Today, the FDA has issued approvals to produce pharmaceuticals for sale in the United States to some 900 manufacturing plants in India, giving Indian companies a legitimacy that potential rivals in places such as China lack. For Western enterprises, the obvious attraction of outsourcing drug manufacturing to India is that it lowers their costs, enabling them to protect their earnings in an increasingly difficult domestic environment where government health care regulation and increased competition have put pressure on the pricing of many pharmaceuticals. Arguably, this also benefits consumers in the United States because lower pharmaceutical prices mean lower insurance costs, smaller pays, and ultimately lower out-of-pocket expenses than if those pharmaceuticals were still manufactured domestically. Offset against this economic benefit, of course, must be the cost of jobs lost in U.S. pharmaceutical manufacturing. Indicative of this trend, total manufacturing. Indicative of this trend, total manufacturing employment in this sector fell by 5 percent between 2008 and 2010. QUESTIONS TO ANSWER 1. Explain how might (a) U.S. pharmaceutical companies and (b) U.S. consumers benefit from the rise of the Indian pharmaceutical industry? (5 Marks) 2. Do the benefits from trade with the Indian pharmaceutical sector outweigh the losses for US pharmaceutical market? Discuss. (5 Marks) 3. What international trade theory (or theories) best explains the rise of India as a major exporter of pharmaceuticals? (5 Marks)
Expert Answer:
Answer rating: 100% (QA)
1 Benefits to the manufacturers It lowers cost by outsourcing drug manufacturing to India Enable the... View the full answer
Related Book For
Posted Date:
Students also viewed these business communication questions
-
Do you think that IACs such as the United States should open their doors wider to the immigration of low-skilled DVC workers in order to help the DVCs develop? Do you think that it is appropriate for...
-
One of the great new "marketplaces" of our time is eBay. Spend some time on the eBay Web site (www.ebay.com). Find a product that you are interested in and follow the bidding. How much would you be...
-
Why do developed countries such as the United States regulate trade through the mechanisms described in this section? Why might a less developed country do so? To promote fair trade the WTO prohibits...
-
In April 1999, one of Capital Blue Cross' health-care insurance plans had been in the field for three years, but hadn't performed as well as expected. The ratio of premiums to claims payments wasn't...
-
Suppose that X and Y are discrete random variables with the joint pdf (x, y) fX,Y(x, y) (1, 2)..1/2 (1, 3)..1/4 (2, 1)..1/8 (2, 4)..1/8 Find the correlation coefficient between X and Y.
-
Determine the total allowable 2010 earned income credit in each of the following situations: a. Rina is single and earns $6,300 in salary for the year. In addition, she receives $1,450 in...
-
Consider the following cash flow profile and assume MARR is 10 percent/year. a. What does Descartes' rule of signs tell us about the IRR(s) of this project? b. What does Norstrom's criterion tell us...
-
Jamison Woodworking uses normal costing and allocates manufacturing overhead to jobs based on a budgeted labor-hour rate and actual direct labor-hours. Under-or overallocated overhead, if immaterial,...
-
Why is it difficult to determine award amounts in wrongful life cases? I. The cost for an entire lifetime is difficult to determine II. The cost is usually determined by comparing the "injured" with...
-
(a) Write a Python function called lroot to calculate the largest root of the quadratic equation ax +bx+c= 0. Your function should take the coefficients a, b and c as arguments and return the largest...
-
Why do the instruments used in ancient times work only on sunny days?
-
what is the difference between managerial and financial accounting? Q 2 ) what are the manufacturing and non manufacturing cost and describe the types of them? Q 3 ) advantages and disadvantages of...
-
What is the difference between S and C in the heat calculated from calorimetry calculation? q=m*S*At=C*At
-
Considering the life cycle of a glass of orange juice from a Florida orange grove, name five raw materials that need to be acquired and how that material is used to make a glass of orange juice...
-
Time-And-Material Pricing How are wages and benefits, overhead costs, and desired profit margins related to one another?
-
what is the foreign tax credit? how it can positively contribute to the investent in foreign countries? explain with numerical cases foreign tax limitations : the overall limitation and country by...
-
(b) Suppose an individual borrows an amount of K28, 300 for 10 months at an interest rate of 9.25%. Calculate (i) The interest due on the loan. (ii) The maturity value at the end of 10 months.. (c)...
-
Show that the peak of the black body spectrum as a function of ? is given by eq. (22.14) kg T Wmax = 2.82
-
Conduct your own research to learn more about Fabletics. Discuss how Fabletics is meeting customer needs through its value delivery network. What controversy surrounds the company?
-
Suppose you are conducting market research for your favorite soda brand. Sales have been lagging for two quarters, and you are determined to find out why. You decide to host an in-person focus group...
-
Researchers study the role of personality on consumer purchase behavior. One research project-Beyond the Purchase-offers a range of surveys consumers can take to learn more about their own...
-
Go to https://www.youtube.com/watch?v=Fp9m4GNwGng to view a brief video on the Brazilian Jet manufacturer Embraer and their use of Critical Chain Project Management for maintenance services. How has...
-
It is sometimes argued that state revenue generated by lotteries is different from tax revenue because people choose to buy lottery tickets. Compare three state revenue sources cigarette excise...
-
Suppose that the demand for personalized license plates and the marginal cost of production in a state is as shown in Figure 16.1. If all the profits go to the government and the state wants to...
Study smarter with the SolutionInn App